Literature DB >> 24657531

CTCF and BORIS in genome regulation and cancer.

Amy D Marshall1, Charles G Bailey1, John E J Rasko2.   

Abstract

CTCF plays a vital role in chromatin structure and function. CTCF is ubiquitously expressed and plays diverse roles in gene regulation, imprinting, insulation, intra/interchromosomal interactions, nuclear compartmentalisation, and alternative splicing. CTCF has a single paralogue, the testes-specific CTCF-like gene (CTCFL)/BORIS. CTCF and BORIS can be deregulated in cancer. The tumour suppressor gene CTCF can be mutated or deleted in cancer, or CTCF DNA binding can be altered by epigenetic changes. BORIS is aberrantly expressed frequently in cancer, leading some to propose a pro-tumourigenic role for BORIS. However, BORIS can inhibit cell proliferation, and is mutated in cancer similarly to CTCF suggesting BORIS activation in cancer may be due to global genetic or epigenetic changes typical of malignant transformation.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24657531     DOI: 10.1016/j.gde.2013.10.011

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  26 in total

1.  Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I.

Authors:  Rodrigo Peña-Hernández; Maud Marques; Khalid Hilmi; Teijun Zhao; Amine Saad; Moulay A Alaoui-Jamali; Sonia V del Rincon; Todd Ashworth; Ananda L Roy; Beverly M Emerson; Michael Witcher
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

2.  BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells.

Authors:  Sanne Marlijn Janssen; Roy Moscona; Mounib Elchebly; Andreas Ioannis Papadakis; Margaret Redpath; Hangjun Wang; Eitan Rubin; Léon Cornelis van Kempen; Alan Spatz
Journal:  Cell Death Discov       Date:  2020-01-02

3.  Promoter-Enhancer Communication Occurs Primarily within Insulated Neighborhoods.

Authors:  Fei Sun; Constantinos Chronis; Michael Kronenberg; Xiao-Fen Chen; Trent Su; Fides D Lay; Kathrin Plath; Siavash K Kurdistani; Michael F Carey
Journal:  Mol Cell       Date:  2018-12-06       Impact factor: 17.970

Review 4.  A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.

Authors:  Craig L Parfett; Daniel Desaulniers
Journal:  Int J Mol Sci       Date:  2017-06-01       Impact factor: 5.923

Review 5.  Enhancer reprogramming in tumor progression: a new route towards cancer cell plasticity.

Authors:  Luca Fagnocchi; Vittoria Poli; Alessio Zippo
Journal:  Cell Mol Life Sci       Date:  2018-04-24       Impact factor: 9.261

Review 6.  CTCF and CTCFL in cancer.

Authors:  Roxanne E Debaugny; Jane A Skok
Journal:  Curr Opin Genet Dev       Date:  2020-04-22       Impact factor: 5.578

7.  Release of transcriptional repression via ErbB2-induced, SUMO-directed phosphorylation of myeloid zinc finger-1 serine 27 activates lysosome redistribution and invasion.

Authors:  Ditte Marie Brix; Siri Amanda Tvingsholm; Malene Bredahl Hansen; Knut Bundgaard Clemmensen; Tiina Ohman; Valentina Siino; Matteo Lambrughi; Klaus Hansen; Pietri Puustinen; Irina Gromova; Peter James; Elena Papaleo; Markku Varjosalo; José Moreira; Marja Jäättelä; Tuula Kallunki
Journal:  Oncogene       Date:  2019-01-08       Impact factor: 9.867

8.  BORIS Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through GALNT14.

Authors:  Joanna C Hillman; Elena M Pugacheva; Carter J Barger; Sirinapa Sribenja; Spencer Rosario; Mustafa Albahrani; Alexander M Truskinovsky; Aimee Stablewski; Song Liu; Dmitri I Loukinov; Gabriel E Zentner; Victor V Lobanenkov; Adam R Karpf; Michael J Higgins
Journal:  Mol Cancer Res       Date:  2019-07-10       Impact factor: 6.333

9.  CCCTC-binding factor recruitment to the early region of the human papillomavirus 18 genome regulates viral oncogene expression.

Authors:  Christian Paris; Ieisha Pentland; Ian Groves; David C Roberts; Simon J Powis; Nicholas Coleman; Sally Roberts; Joanna L Parish
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

10.  Epigenetics of the myotonic dystrophy-associated DMPK gene neighborhood.

Authors:  Lauren Buckley; Michelle Lacey; Melanie Ehrlich
Journal:  Epigenomics       Date:  2016-01-12       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.